1Panza,F,DIntrono A,Colacicco AM et al.Vascular risk and genetics of sporadic late-ons et alzheimer's disease.J Neural Transm,2004;111(1):69～89
2Bjorkhem I,Meaney S.Brain cholesterol:long secret life behind a barrier.Arterioscler Thromb Vasc Biol,2004;24(5):806～815
3Lane RM.Farlow MR.Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease.J Lipid Res,2005;46(5):949～968
4Poirier J.Apolipoprotein E.cholesterol transport and synthesis in sporadic Alzheimer'S disease.Neurobiol Aging,2005;26(3):355～361
5Dufouil C,Richard F,Fievet N et al.APOE genotype,cholesterol level,lipid-lowering treatment,and dementia.Neurology,2005;64(9):1531～1538
6Reitz C,Tang MX,Luchsinger J et al.Relation of plasma lipids to Alzheimer disease and vascular dementia.Arch Neurol,2004;61(5):705～714
7Whitmer RA,Sidney S,Selby J et al.Midlife cardiovascular risk factors and risk of dementia in late life.Neurology,2005;64(2):277～281
8Mielke MM,Zanidi PP,Sjogren M et al.High total cholesterol levels in late life associated with a reduced risk of dementia.Neurology,2005;64(10):1689～1695
9Panza F,Solfrizzi V,Colacicco AM et al.Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians.Neuro Report,2003;14(4):605～608
10Gavrilova SI,Kolykhalov IV,Korovaitseva GI et al.ApoE genotype and efficacy of neurotrophic and cholinergic therapy in Alzheimer's disease.Zh Nevrol Psikhiatr Im S S korsakova,2005;105(4):27～34
